ID   CCX.E10
AC   CVCL_E4II
RX   CelloPub=CLPUB00780;
RX   PubMed=37584190;
WW   https://nuvonis.com/ccx-cell-line/
CC   Group: Bird cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Nuvonis Technologies GmbH; Vienna; Austria.
CC   Biotechnology: Can be used for the manufacturing of the fusogenic oncolytic virus, rVSV-NDV, a recombinant vesicular stomatitis virus (VSV) backbone with fusogenic mutant glycoproteins of Newcastle disease virus (NDV) (PubMed=37584190).
CC   Characteristics: Grows in suspension (Nuvonis).
CC   Virology: When infected with Newcastle disease virus (NDV) produces high viral titers (CelloPub=CLPUB00780).
CC   Doubling time: 0.8-1 day (Nuvonis).
CC   Miscellaneous: Age at sampling from personal communication of Seipelt, Joachim.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
OI   CVCL_E4IH ! CCX.2C4
SX   Sex unspecified
AG   12FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   CelloPub=CLPUB00780;
RA   Jug H., Hosta N., Tajnik Sbaizero M., Strancar A., Brodesser D.M.,
RA   Tisch B., Heger T., Wolschek M., Seipelt J., Reiter M.;
RT   "Production and purification of Newcastle disease virus.";
RL   BioProcess Int. 21:17-20(2023).
//
RX   PubMed=37584190; DOI=10.1002/bit.28530;
RA   Gobel S., Jaen K.E., Fernandes R.P., Reiter M., Altomonte J., Reichl U.,
RA   Genzel Y.;
RT   "Characterization of a quail suspension cell line for production of a
RT   fusogenic oncolytic virus.";
RL   Biotechnol. Bioeng. 120:3335-3346(2023).
//